- Home
- ABVC vs FORA Comparison
ABVC vs FORA Comparison
Compare ABVC & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABVC | FORA |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.6M | 69.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ABVC | FORA |
|---|---|---|
| Price | $2.08 | $2.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 68.8K | 36.0K |
| Earning Date | 11-03-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $797,916.00 | ★ $28,106,911.00 |
| Revenue This Year | $735.18 | $47.82 |
| Revenue Next Year | N/A | $10.11 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 56.52 | 37.47 |
| 52 Week Low | $0.40 | $1.64 |
| 52 Week High | $5.48 | $4.03 |
Technical Indicators
Market Signals| Indicator | ABVC | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 31.30 | 47.13 |
| Support Level | $2.06 | $2.11 |
| Resistance Level | $2.30 | $2.19 |
| Average True Range (ATR) | 0.17 | 0.07 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 12.71 | 55.00 |
Price Performance
Historical ComparisonAbout ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.